Interstitial granulomatous dermatitis following tocilizumab, a paradoxical reaction?-Reference-Cited by-同舟云学术

Interstitial granulomatous dermatitis following tocilizumab, a paradoxical reaction?

Published:2020-09-07 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Altemir Arcadi¹^ORCID,Iglesias‐Sancho Maribel¹,Sola‐Casas María de los Ángeles¹,Novoa‐Lamazares Luis¹,Fernández‐Figueras Maite²,Salleras‐Redonnet Montse¹

Affiliation:

1. Department of Dermatology Hospital Universitari Sagrat Cor, Grupo Quirónsalud Barcelona Spain

2. Department of Pathology Hospital Universitari General de Catalunya, Grupo Quirónsalud, Universitat internacional de Catalunya, Sant Cugat del Vallès Barcelona Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14207

Reference15 articles.

1. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern

2. Reactive Granulomatous Dermatitis

3. Interstitial Granulomatous Dermatitis With Arthritis Responding to Tocilizumab

4. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

5. Onset of psoriasis following treatment with tocilizumab

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Reactive granulomatous dermatitis presenting with inguinal erythematous plaques in a patient administered with pravastatin;Journal of Cutaneous Immunology and Allergy;2024-09-02

2. Interstitial Granulomatous Dermatitis and Palisaded Neutrophilic Granulomatous Dermatitis: Retrospective Clinicopathological Analysis of 16 cases;Dermatology Practical & Conceptual;2023-07-31

3. Underlying Systemic Diseases in Interstitial Granulomatous Dermatitis and Palisaded Neutrophilic Granulomatous Dermatitis: A Systematic Review;Dermatology;2022-12-07

4. Benralizumab-induced interstitial granulomatous dermatitis: A case report;Therapies;2022-09

5. Palisaded neutrophilic granulomatous dermatitis as a paradoxical adverse reaction following tocilizumab use;International Journal of Dermatology;2022-07-05